Skip Navigation

European Heart Journal 2000 21(23):1897-1901; doi:10.1053/euhj.2000.2141
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by White, H.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, H.D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Hotline Editorial

Cardiogenic shock: a more aggressive approach is now warranted

H.D. White

Green Lane Hospital, Auckland, New Zealand

References

  1. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162–1168[Abstract/Free Full Text]
  2. Berger PB, Tuttle RH, Holmes DR Jr. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I Trial. Circulation. 1999;99:873–878[Abstract/Free Full Text]
  3. Hasdai D, Holmes DR Jr, Topol EJ. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase: results from GUSTO-III. Eur Heart J. 1999;20:128–135[Abstract/Free Full Text]
  4. Gunnar RM. Cardiogenic shock complicating acute myocardial infarction. Circulation. 1988;78:1508–1510[Free Full Text]
  5. French JK, White HD. Generalization of trial and registry cohort results to individual patients with cardiogenic shock. ACC Current Journal Review. 1999;8:7–11
  6. Urban P, Stauffer J-C, Bleed D. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction: the (Swiss) Multicenter Trial of Angioplasty for Shock—(S)MASH. Eur Heart J. 1999;20:1030–1038[Abstract/Free Full Text]
  7. Hochman JS, Sleeper LA, Webb JG. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625–634[Abstract/Free Full Text]
  8. Hochman JS, Gersh BJ. Acute myocardial infarction: complications. Topol EJ. Textbook of cardiovascular medicine. Philadelphia: Lippincott-Raven Publishers; 1998. p. 437–480
  9. Lancet. 1986;i:397–402
  10. Lancet. 1994;343:311–322[CrossRef][ISI][Medline]
  11. Waksman R, Weiss AT, Gotsman MS, Hasin Y. Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. Eur Heart J. 1993;14:71–74[Abstract/Free Full Text]
  12. Hudson MP, Granger CB, Stebbins AL. Cardiogenic shock survival and use of intraaortic balloon counterpulsation: results from the GUSTO I and III Trials (Abstr). Circulation. 1999;100:I-370
  13. Chesebro JH, Knatterud G, Roberts R. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation. 1987;76:142–154[Abstract/Free Full Text]
  14. Beyersdorf F, Buckberg GD, Acar C. Cardiogenic shock after acute coronary occlusion—pathogenesis, early diagnosis and treatment. Thorac Cardiovasc Surg. 1989;37:28–36[ISI][Medline]
  15. Gibson RS, Bishop HL, Stamm RB, Crampton RS, Beller GA, Martin RP. Value of early two dimensional echocardiography in patients with acute myocardial infarction. Am J Cardiol. 1982;49:1110–1119[CrossRef][ISI][Medline]
  16. White HD, Stewart JT, Aylward PEG. Angioplasty versus surgery for cardiogenic shock: results from the SHOCK trial (Abstr). Circulation. 1999;100:I-370
  17. Picard MH, Davidoff R, Mendes LA. Determinants of mortality from cardiogenic shock: observations from the SHOCK trial (Abstr). Circulation. 1999;100:I-19
  18. White HD, Cross DB, Elliott JM, Norris RM, Yee TW. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation. 1994;89:61–67[Abstract/Free Full Text]
  19. Hasdai D, Califf RM, Thompson TD. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol. 2000;35:136–143[Abstract/Free Full Text]
  20. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. Am J Med. 1993;94:265–273[CrossRef][ISI][Medline]
  21. Hands ME, Rutherford JD, Muller JE. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. J Am Coll Cardiol. 1989;14:40–46[Abstract]
  22. Hasdai D, Lerman A, Rihal CS. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. Am Heart J. 1999;137:612–620[CrossRef][ISI][Medline]
  23. Menon V, Slater JN, White HD, Sleeper LA, Cocke T, Hochman JS. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK Trial Registry. Am J Med. 2000;108:374–380[CrossRef][ISI][Medline]
  24. Ellis SG, Wynne J, Braunwald E, Henschke CI, Sandor T, Kloner RA. Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation. Am Heart J. 1984;107:13–19[CrossRef][ISI][Medline]
  25. Webb JG, Carere RG, Hilton JD. Usefulness of coronary stenting for cardiogenic shock. Am J Cardiol. 1997;79:81–84[CrossRef][ISI][Medline]
  26. de Lemos JA, Antman EM, Gibson CM. Abciximab improves both epicardial flow and myocardial reperfusion in ST elevation myocardial infarction: observations from the TIMI 14 trial. Circulation. 2000;1011:239–243
  27. Choudhri TF, Hoh BL, Zerwes H-G. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest. 1998;102:1301–1310[ISI][Medline]
  28. Schultz RD, Heuser RR, Hatler C, Frey D. Use of c7E3 Fab in conjunction with primary coronary stenting for acute myocardial infarctions complicated by cardiogenic shock. Cathet Cardiovasc Diagn. 1996;39:143–148[CrossRef][ISI][Medline]
  29. Giri S, Kiernan FJ, Mitchel JF. Synergistic interaction between intracoronary stenting and IIb/IIIa inhibition for improving clinical outcomes in primary angioplasty for cardiogenic shock (Abstr). Circulation. 1999;100:I-380
  30. Hasdai D, Kitt MM, Harrington RA. Impact of platelet glycoprotein IIb/IIIa blockade on outcome of cardiogenic shock among patients with acute coronary syndromes without persistent ST-segment elevation (Abstr). Circulation. 1999;100:I-433
  31. Sleeper LA, LeJemtel TH, Godfrey E. Functional capacity following emergency revascularization in cardiogenic shock patients: preliminary results from the SHOCK Trial (Abstr). J Am Coll Cardiol. 2000;35:393A
  32. Ryan TJ, Antman EM, Brooks NH. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1999;34:890–911[Free Full Text]
  33. Lancet. 1988;i:545–549
  34. Wilcox RG, von der Lippe G, Ollson CG, Jensen G, Skene AM, Hampton JR. Trial of tissue plasminogen activation for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988;ii:525–530
  35. Antman EM, Giugliano RP, Gibson CM. Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial. Circulation. 1999;99:2720–2732[Abstract/Free Full Text]
  36. White HD, Aylward PE, Frey MJ. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Circulation. 1997;96:2155–2161[Abstract/Free Full Text]
  37. N Engl J Med. 1996;335:775–782[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
U. Zeymer, A. Vogt, R. Zahn, M. A Weber, U. Tebbe, M. Gottwik, T. Bonzel, J. Senges, K.-L. Neuhaus, and for the Arbeitsgemeinschaft Leitende Kardiologisch
Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI): Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK)
Eur. Heart J., February 2, 2004; 25(4): 322 - 328.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
J. Ducas and E. D Grech
Percutaneous coronary intervention: cardiogenic shock
BMJ, June 25, 2003; 326(7404): 1450 - 1452.
[Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by White, H.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, H.D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?